Strategy | Cost (RMB) | Incremental costs | Effectiveness | Incremental effectiveness | C/E | Incremental C/E (ICER) |
|
|
|
|
|
|
|
Glimepiride + metformin | 210,502.91 |
| 16.68 QALY |
| 12,620.07 |
|
1.2 mg | 265,854.60 | 55,351.69 | 16.68 QALY | 0 | 15,938.53 | 0 |
1.8 mg | 293,174.43 | 82,671.49 | 16.80 QALY | 0.12 | 17,450.86 | 40,256.58 |